Evidence-Based Practice Guideline of NGC in Sepsis Management

Running Head: EVIDENCE-BASED PRACTICE GUIDELINE
EVIDENCE-BASED PRACTICE GUIDELINE OF NGC IN SEPSIS MANAGEMENT

EVIDENCE-BASED PRACTICE GUIDELINE
Introduction
Evidence-based practice (EBP) guidelines make use of systematic reviews for providing
information in case of specific clinical circumstances (Sniderman & Furberg, 2009). Clinical
questions, in turn, encompass a systematic review of the literature undertaken for identification
of evidence for catering to the clinical questions. The methodology and science involved have
evolved in evidence-based practice, focusing upon providing recommendations from the
literature of medicine. Evidence is first summarized, then graded and finally presented for
improvising the quality of patient care and supporting it with interventions regarding the benefits
(Buchan, Currie, Lourey & Duggan, 2010). In the current scope of discussion, a database has
been identified to locate an evidence-based practice guideline and then analyze the same. The
current evaluation will undertake the National Guideline Clearinghouse database related to
Sepsis Management for analyzing the same.
Analysis of Database
The module reflected defining evidentialism and EBP, further explaining the importance
preference of patient (Melnyk & Fineout-Overholt, 2011). It is crucial to note that patient
preference with values and nurses’ clinical expertise needs to be integrated with extensive
research. It enables arrive at a decision which can lead to healthcare outcomes in a positive
manner (Norris, Holmer, Ogden & Burda, 2011). Searching through Google by searching
‘practice guideline’, one guideline of the National Guideline Clearinghouse was aimed to be
evaluated.
2

EVIDENCE-BASED PRACTICE GUIDELINE
The guideline developers include the NGC mission that provides physicians and other
health care providers, health professionals, purchasers, integrated delivery system and others for
information on clinical guidelines, objectives for implementing and dissemination (DPHP,
2011). The U.S. Department of Health and Human Services and the Agency of Healthcare
Research and Quality (AHRQ) initiative developed the NGC. The organization does not include
professionals that can directly cater to queries of the patient or provide advice regarding
experiences or health-related issues. The National Clinical Guidelines are considered systematic
developed statements by evaluation of evidence (Casey, 2013). It is developed for assisting
practitioner along with service users regarding the decision of appropriate healthcare in order to
attain to specific clinical situations. The Sepsis Management guideline has been developed to
cater to a wide range of receivers of healthcare and service users.
The developers of the guideline representative of key stakeholders in this specialty
(inter-disciplinary): The guideline developers were representative of key stakeholders in the
specialty area. The NGC's Sepsis management primary guidelines No. 6, comprised of clinical
guidelines that document with the focus on guiding decision criteria related to managing,
diagnosing and treating certain healthcare focus (Dawes, 2010). The guideline developers,
designed the guidelines to represent appropriately the various key stakeholders, here comprising
of servicer users and assisting the practitioner. The developer of guidelines in the area of sepsis
management have catered to the individual needs of nurses in emergency department, doctors,
ward nurses and other healthcare professionals. The guidelines provided specific patient-related
information such that service providers can make use of the same. It included definitions, the
pathway for sepsis, detection, screening and all other processes for the varied stakeholder groups
(National Clinical Effectiveness Committee, 2014).
3

EVIDENCE-BASED PRACTICE GUIDELINE
The guideline funding: The guideline was funded by the U.S. Department of Health and
Human Services and the Agency of Healthcare Research and Quality (AHRQ). It was a special
initiative by the U.S. of Health and Human Service to provide a guideline that can attend to and
support clinical decision making when providing care (Norris, Holmer, Ogden, Selph & Fu,
2012). The core aim of the guideline was to provide therapeutic effectiveness, counseling,
evaluation, diagnosis, prevention, management, rehabilitation, risk assessment, technology
evaluation, screening and treatment purposes.
The guideline developers funded researchers of the reviewed studies: The guidelines
developers contributed significantly towards the funding of various researchers of the reviewed
studies. The guidelines have been developed with several assessment and researchers conducted
and published by the National Clinical Guideline Centre (Alonso-Coello et al, 2011). These
researchers have been published under varied categories such that users can easily search
guidelines.
The team has a valid development strategy: The development team funded by the U.S.
government department and AHRQ have a valid strategy for intervention and producing clinical
guidelines. The guidelines have been developed in several clinical areas of interventions and
most of them have been supported and backed by a study published by the National Clinical
Guideline Centre (Kung, Miller & Mackowiak, 2012). Firstly, the recommendation is provided
from past literature source and then there is a backing of suitable and appropriate rationale. This
strategy convinces the user to apply them for cases of sepsis management. Not only does the
guideline have a valid developmental process and methodology for clinical guideline setting
rather it included an ISBAR communication tool, which can be applied in case any patient
4